Macula densa basolateral ATP release is regulated by luminal [NaCl] and dietary salt intake.
One component of the macula densa (MD) tubuloglomerular feedback (TGF) signaling pathway may involve basolateral release of ATP through a maxi-anion channel. Release of ATP has previously been studied during a maximal luminal NaCl concentration ([NaCl](L)) stimulus (20-150 mmol/l). Whether MD ATP release occurs during changes in [NaCl](L) within the physiological range (20-60 mmol/l) has not been examined. Also, because TGF is known to be enhanced by low dietary salt intake, we examined the pattern of MD ATP release from salt-restricted rabbits. Fluorescence microscopy, with fura 2-loaded cultured mouse mesangial cells as biosensors, was used to assess ATP release from the isolated, perfused thick ascending limb containing the MD segment. The mesangial biosensor cells, which contain purinergic receptors and elevate intracellular Ca(2+) concentration ([Ca(2+)](i)) on ATP binding, were placed adjacent to the MD basolateral membrane. Elevations in [NaCl](L) between 0 and 80 mmol/l, in 20-mmol/l increments, caused stepwise increases in [Ca(2+)](i), with the highest increase at [NaCl](L) of approximately 60 mmol/l. Luminal furosemide at 10(-4) mol/l blocked ATP release, which suggests that the efflux of ATP required MD Na-2Cl-K cotransport. A low-salt diet for 1 wk increased the magnitude of [NaCl](L)-dependent elevations in biosensor [Ca(2+)](i) by twofold, whereas high-salt intake had no effect. In summary, ATP release occurs over the same range of [NaCl](L) (20-60 mmol/l) previously reported for TGF responses, and, similar to TGF, ATP release was enhanced by dietary salt restriction. Thus these two findings are consistent with the role of MD ATP release as a signaling component of the TGF pathway.
Komlosi
Peter
P
865 Sparks Center, 1720 Seventh Ave. South, Birmingham, AL 35294, USA. pkomlosi@uab.edu
Peti-Peterdi
Janos
J
Fuson
Amanda L
AL
Fintha
Attila
A
Rosivall
Laszlo
L
Bell
Phillip Darwin
PD
D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D015374:Biosensing Techniques; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D004032:Diet; D004232:Diuretics / Q000494:pharmacology; D005456:Fluorescent Dyes; D016257:Fura-2; D005665:Furosemide / Q000494:pharmacology; D005920:Glomerular Mesangium / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D007684:Kidney Tubules / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D007686:Kidney Tubules, Distal / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D008856:Microscopy, Fluorescence; D058913:Purinergic Agonists; D011817:Rabbits; D012965:Sodium Chloride / Q000494:pharmacology*; D017673:Sodium Chloride, Dietary / Q000494:pharmacology*
D004232:Diuretics; D005456:Fluorescent Dyes; D058913:Purinergic Agonists; D017673:Sodium Chloride, Dietary; D012965:Sodium Chloride; D005665:Furosemide; D000255:Adenosine Triphosphate; D002118:Calcium; D016257:Fura-2